Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice

Authors

• Eduard Puente-Massaguer, Icahn School of Medicine at Mount Sinai, USAFollow
• Kirill Vasilev, Department of Microbiology, ISMMS, New York, USA
• Benjamin Francis, Department of Microbiology, ISMMS, New York, USA
• Madhumathi Loganathan, Department of Microbiology, ISMMS, New York, USA
• Guha Asthagiri Arunkumar, Department of Microbiology, ISMMS, New York, USA
• Michael J. Scherm, Department of Microbiology, ISMMS, New York, USA
• Irene Gonzalez-Dominguez, Department of Microbiology, ISMMS, New York, USA
• Annika Beyer, Department of Microbiology, ISMMS, New York, USA
• Xueyong Zhu, Department of Integrative Structural and Computational Biology, The Scripps Research Institute, USA
• Lynda Coughlan, Department of Integrative Structural and Computational Biology, The Scripps Research Institute, USA
• Ian A. Wilson, Department of Integrative Structural and Computational Biology, The Scripps Research Institute, USA
• Weina Sun, Department of Microbiology, ISMMS, New York, USA
• Florian Krammer, Department of Microbiology, ISMMS, New York, USA
• Peter Palese, Department of Microbiology, ISMMS, New York, USA

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Eduard Puente-Massaguer, Kirill Vasilev, Benjamin Francis, Madhumathi Loganathan, Guha Asthagiri Arunkumar, Michael J. Scherm, Irene Gonzalez-Dominguez, Annika Beyer, Xueyong Zhu, Lynda Coughlan, Ian A. Wilson, Weina Sun, Florian Krammer, and Peter Palese, "Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/65